Bacille Calmette-Guerin vaccination enhances human γδ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 1045-1054

  Hoft, Daniel F ^a,b   Brown, Robin M ^a   Roodman, Stanford T ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; BACTERIAL ANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; ISOPRENOID PHOSPHATE; LYMPHOCYTE ANTIGEN RECEPTOR; PLACEBO;

ARTICLE; CELL PROTECTION; CROSS REACTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMORY CELL; MYCOBACTERIUM; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VACCINATION; ADOLESCENT; ADULT; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL FRACTIONATION; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METABOLISM; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL FRACTIONATION; CELLS, CULTURED; EPITOPES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PLACEBOS; POLYISOPRENYL PHOSPHATES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 0032527122     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J. Am. Med. Assoc. 271:698.
2. Colditz, G. A., C. S. Berkey, F. Mosteller, T. F. Brewer, M. E. Wilson, E. Burdick, and H. V. Fineberg. 1995. The efficacy of Bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: metaanalyses of the published literature. Pediatrics 96:29.
3. Jacobs, W. R., S. B. Snapper, M. Tuckman, and B. R. Bloom. 1989. Mycobacteriophage vector systems. Rev. Infect. Dis. 11:5404.
4. Husson, R. N., B. E. James, and R. A. Young. 1990. Gene replacement and expression of foreign DNA in mycobacteria. J. Bacteriol 172:519.
5. Barletta, R. G., B. Snapper, J. D. Cirillo, N. D. Connell, D. D. Kim, W. R. Jacobs, and B. R. Bloom. 1990. Recombinant BCG as a candidate oral vaccine vector. Res. Microbiol. 141:931.
6. Collins, F. M. 1991. Antituberculous immunity: new solutions to an old problem. Rev. Infect. Dis. 13:940.
7. Connell, N. D., E. Medina-Acosta, W. R. McMaster, B. R. Bloom, and D. G. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90:11473.
8. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
9. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277.
10. + T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:161.
11. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
12. Flesch, I., and S. H. E. Kaufmann. 1987. Mycobacterial growth inhibition by interferon-activated bone marrow macrophages and differential susceptibility amongst strains of Mycobacterium tuberculosis. J. Immunol. 138:4408.
13. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189.
14. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518.
15. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
16. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178:2243.
17. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
18. Kamijo, R., D. Shapiro, J. Gerecitano, J. Le, M. Bosland, and J. Vilcek. 1994. Biological functions of IFN-γ and IFN-α/β: lessons from studies in gene knock-out mice. Hokkaido J. Med. Sci. 69:1332.
19. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
20. Bloom, B. R., J. Flynn, K. McDonough, Y. Kress, and J. Chan. 1994. Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection. Immunobiology 191:526.
21. Kaufmann, S. H. E., and C. H. Ladel. 1994. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis. Immunobiology 191:509.
22. Barnes, P. F., V. Mehra, B. Rivoire, S. J. Fong, P. J. Brennan, M. S. Voegtline, P. Minden, R. A. Houghten, B. R. Bloom, and R. L. Modlin. 1992. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J. Immunol. 148:1835.
23. Mehra, V., J. Gong, D. Iyer, Y. Lin, C. T. Boylen, B. R. Bloom, and P. F. Barnes. 1996. Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J. Infect. Dis. 174:431.
24. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673.
25. Kemp, E. B., R. B. Belshe, and D. F. Hoft. 1996. Immune responses stimulated by percutaneous and intradermal Bacille Calmette-Guérin. J. Infect. Dis. 174:113.
26. Ravn, P., H. Boesen, B. K. Pedersen, and P. Andersen. 1997. Human T cell responses induced by vaccination with Mycobacterium bovis Bacillus Calmette-Guérin. J. Immunol. 158:1949.
27. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the IFN-γ receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
28. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. Emile, M. J. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J. Casanova. 1996. Interferon receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956.
29. Del Prete, G. F., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara cams expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346.
30. Haanen, J. B. A. G., R. de Waal Malefijt, P. C. M. Res, E. M. Kraakman, T. H. M. Ottenhoff, R. R. P. de Vries, and H. Spits. 1991. Selection of a human T helper type 1-like T cell subset by mycobacteria. J. Exp. Med. 174:583.
31. Barnes, P. F., J. S. Abrams, S. Lu, P. A. Sieling, T. H. Rea, and R. L. Modlin. 1993. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect. Immun. 61:197.
32. Rook, G. A. W., B. R. Champion, J. Steele, A. M. Varey, and J. L. Stanford. 1985. I-A restricted activation by T cell lines of anti-tuberculous activity in murine macrophages. Clin. Exp. Immunol. 159:414.
33. Havlir, D. V., J. J. Ellner, K. A. Chervenak, and W. H. Boom. 1991. Selective expansion of human γ/δ T cells by monocytes infected live Mycobacterium tuberculosis. J. Clin. Invest. 87:729.
34. Boom, W. H., K. A. Chervenak, M. A. Mincek, and J. J. Ellner. 1992. Role of the mononuclear phagocyte as an antigen-presenting cell for human γ/δ T cells activated by live Mycobacterium tuberculosis. Infect. Immun. 60:3480.
35. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. J. Immunol. 154:1786.
36. Li, B., M. D. Rossman, I. Turgut, A. F. Oner-Eyuboglu, C. W. Lee, R. Biancaniello, and S. R. Carding. 1996. Disease-specific changes in γ/δ T cell repertoire and function in patients with pulmonary tuberculosis. J. Immunol. 157:4222.
37. - T lymphocytes to a microbial antigen. Nature 360:593.
38. + T cells. Nature 372:691.
39. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Prigozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, and R. L. Modlin. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227.
40. + human γδ T cells. J. Immunol. 148:575.
41. School, B., S. Springer, and S. H. E. Kaufmann. 1994. Phosphate is essential for stimulation of Vγ9/Vδ2 T lymphocytes by mycobacterial low molecular weight ligand. Eur. J. Immunol. 24:1886.
42. Lang, F., M. A. Peyrat, P. Constant, F. Davodeau, J. David-Ameline, Y. Poquet, H. Vié, J. J. Fournié, and M. Bonneville. 1995. Early activation of human Vγ9δ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial Ligands. J. Immunol. 154:5986.
43. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human γ/δ T cells. Proc. Natl. Acad. Sci. USA 91:8175.
44. Tanaka, Y., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human δ T cells. Nature 375:155.
45. Morita, C. T., E. M. Beckman, J. F. Bukowski, Y. Tanaka, H. Band, B. R. Bloom, D. E. Golan, and M. B. Brenner. 1995. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human δ T cells. Immunity 3:495.
46. Wesch, D., S. Marx, and D. Kabelitz. 1997. Comparative analysis of α/β and γ/δ T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur. J. Immunol. 27:952.
47. Havlir, D. V., R. S. Wallis, W. H. Boom, T. M. Daniel, K. Chervenak, and J. J. Ellner. 1991. Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:665.
48. Andersen, P., D. Askgaard, L. Ljungqvist, M. Weis Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 59:1558.
49. Andersen, P., and I. Heron. 1993. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect. Immun. 61:844.
50. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781.
51. Horwitz, M. A., B. E. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
52. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648.
53. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immu-nol. 154:3359.
54. Brandt, L., T. Oettinger, A. Holm, A. B. Andersen, and P. Andersen. 1996. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157:3527.
55. Hoft, D. F., E. B. Kemp, M. Mariano, O. Cruz, H. Kiyono, J. R. McGhee, J. T. Belisle, T. W. Milligan, J. P. Miller, and R. B. Belshe. 1997. A double blind, placebo controlled study of mycobacterial specific human immune responses induced by intradermal BCG vaccination. J. Clin. Lab. Med. In press.
56. Fine, P. E. M., and L. C. Rodrigues. 1990. Modern vaccines: mycobacterial diseases. Lancet 335:1016.
57. Sprent, J. 1997. Immunological memory. Curr. Opin. Immunol. 9:371.
58. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
59. Zinkemagel, R. M., M. F. Bachmann, T. M. Kundig, S. Gehen, H. Pirchet, and H. Hengartner. 1996. On immunological memory. Annu. Rev. Immunol. 14:333.
60. Swain, S. L., M. Croft, C. Dubey, L. Haynes, P. Rogers, X. Zhang, and L. M. Bradley. 1996. From naive to memory T cells. Immunol. Rev. 150:143.
61. Sprent, J. 1994. T and B memory cells. Cell 76:315.
62. Ohmen, J. D., P. F. Barnes, C. L. Grisso, B. R. Bloom, and R. L. Modlin. 1994. Evidence for a superantigen in human tuberculosis. Immunity 1:35.
63. Vila, L. M., H. M. Haftel, H. Park, M. Lin, N. C. Romzek, S. M. Hanash, and J. Holoshitz. 1995. Expansion of mycobacterium-reactive γ/δ T cells by a subset of memory helper T cells. Infect. Immun. 63:1211.
64. Pechhold, K., D. Wesch, S. Schondelmaier, and D. Kabelitz. 1994. Primary activation of Vγ9-expressing γ/δγ T cells by Mycobacterium tuberculosis: requirement for Th1-type help and inhibition by IL-10. J. Immunol. 152:4984.
65. Garcia, V. E., P. A. Sieling, J. H. Gong, P. F. Barnes, K. Uyemura, Y. Tanaka, B. R. Bloom, C. T. Morita, and R. L. Modlin. 1997. Single-cell cytokine analysis of γ/δ T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159:1328.
66. Palmer, C. E., and M. W. Long. 1966. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 94:553.
67. Ten Dam, H. G. 1984. Research on BCG vaccination. Adv. Tuberc. Res. 21:79.
68. Fine, P. E. M , J. A. C. Sterne, J. M. Ponnighaus, and R. J. W. Rees. 1994. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344:1245.
69. Fine, P. E. M. 1995. Variations in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339.